Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

• Muhammad Hasan Bashari,
• Fengjuan Fan,
• Sonia Vallet,
• Martin Sattler,
• Melissa Arn,
• Claudia Luckner-Minden,
• Henning Schulze-Bergkamen,
• Inka Zörnig,
• Frederik Marme,
• Andreas Schneeweiss,
• Michael H. Cardone,
• Joseph T. Opferman,
• Dirk Jäger,
• Klaus Podar

Affiliations

Muhammad Hasan Bashari

Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg

Fengjuan Fan

Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg

Sonia Vallet

Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg

Martin Sattler

Dana-Farber Cancer Institute

Melissa Arn

Eutropics, Inc.

Claudia Luckner-Minden

Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg

Henning Schulze-Bergkamen

Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg

Inka Zörnig

Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg

Frederik Marme

Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg

Andreas Schneeweiss

Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg

Michael H. Cardone

Eutropics, Inc.

Joseph T. Opferman

St. Jude Children’s Research Hospital

Dirk Jäger

Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg

Klaus Podar

Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg